Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3039% below fair value
$2.42+0.13 (+5.68%)
Close on Nov 13, 2026Market cap $138.39MP/E –Yield –
Abeona Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Abeona Therapeutics's operating margin for the twelve months ending Sep 30, 2026 was -186.1%. For fiscal 2025 it was -1536.9%, against -1346.7% the year before. The highest annual figure on record is -98.0% in fiscal 2012.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1536.9% | −190.2 |
| FY2023 | Dec 31, 2023 | -1346.7% | +2254.1 |
| FY2022 | Dec 31, 2022 | -3600.8% | −606.2 |
| FY2021 | Dec 31, 2021 | -2994.5% | −2180.3 |
| FY2020 | Dec 31, 2020 | -814.2% | +1126.0 |
| FY2018 | Dec 31, 2018 | -1940.2% | +1385.5 |
| FY2017 | Dec 31, 2017 | -3325.7% | −639.4 |
| FY2016 | Dec 31, 2016 | -2686.3% | −903.0 |
| FY2015 | Dec 31, 2015 | -1783.3% | −1444.8 |
| FY2014 | Dec 31, 2014 | -338.5% | −152.2 |
| FY2013 | Dec 31, 2013 | -186.3% | −88.3 |
| FY2012 | Dec 31, 2012 | -98.0% | +330.3 |
| FY2011 | Dec 31, 2011 | -428.3% | +1184.4 |
| FY2010 | Dec 31, 2010 | -1612.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -96.4% | +5601.6 |
| Q2 FY2026 | Jun 30, 2026 | -120.0% | +181.6 |
| Q1 FY2026 | Mar 31, 2026 | -264.1% | +18759.4 |
| Q4 FY2025 | Dec 31, 2025 | -422.7% | +378.1 |
| Q2 FY2025 | Jun 30, 2025 | -5698.0% | +253.2 |
| Q2 FY2023 | Jun 30, 2023 | -301.5% | +181.1 |
| Q4 FY2022 | Dec 31, 2022 | -19023.5% | −18934.3 |
| Q2 FY2022 | Jun 30, 2022 | -800.8% | +2935.7 |
| Q1 FY2022 | Mar 31, 2022 | -5951.2% | −4961.3 |
| Q4 FY2020 | Dec 31, 2020 | -482.7% | +4067.0 |
| Q3 FY2020 | Sep 30, 2020 | -89.3% | +1922.6 |
| Q4 FY2018 | Dec 31, 2018 | -3736.5% | +333.3 |
| Q3 FY2018 | Sep 30, 2018 | -989.8% | +1458.6 |
| Q2 FY2018 | Jun 30, 2018 | -4549.6% | −660.2 |
| Q1 FY2018 | Mar 31, 2018 | -2011.9% | +829.0 |
| Q4 FY2017 | Dec 31, 2017 | -4069.8% | −1791.6 |
| Q3 FY2017 | Sep 30, 2017 | -2448.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -3889.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -2840.9% | – |
| Q4 FY2016 | Dec 31, 2016 | -2278.1% | – |
See a number that looks wrong?